MedTrace Logo

Family Blood Pressure Program - HyperGEN

NCT00005267 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3604

Last updated 2015-10-08

No results posted yet for this study

Summary

To map and identify the major genetic determinants of hypertension and to study possible interactions between genetic and non-genetic factors in defined populations. HyperGEN initially consisted of a nine grant network, which in turn is part of an NHLBI initiative, the Family Blood Pressure Program (FBPP) consisting of four networks.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Donna Arnett · University of Alabama at Birmingham

  • John Eckfeldt · University of Minnesota

  • R.Curtis Ellison · Boston University

  • Steven Hunt · University of Utah

  • Jean-Marc Lalouel · University of Utah

  • Cora Lewis · University of Alabama at Birmingham

  • Kari North · University of North Carolina

  • James Pankow · University of Minnesota

  • Dabeeru Rao · Washington University School of Medicine

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1995-09-30
Primary Completion
2008-08-31
Completion
2008-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005267 on ClinicalTrials.gov